Found: 2
Select item for more details and to access through your institution.
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 2, p. 236, doi. 10.1038/leu.2011.218
- By:
- Publication type:
- Article
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies.
- Published in:
- 2011
- By:
- Publication type:
- journal article